1. Health care markets and competition policy; 2. Antitrust policy in the United States; Section I. Monopoly: 3 Patents and monopoly pricing of pharmaceuticals; 4. Patents and exclusionary product hopping; 5. Bundled discounts and peace health; Section II. Seller Cartels: 6. Collusion in health care markets; 7.

Collusion in generic drug markets; 8. The hatch-waxman act, patent infringement suits, and reverse payments; Appendix; The economics of settlements; 9. The alleged insulin conspiracy; 10. Licensing of health care professionals; Section III. Monopsony: 11. Monopsony, dominant buyers, and oligopsony; 12. Countervailing power - physician collective bargaining; 13. Group purchasing organizations, monopsony, and antitrust policy; Section IV.

Buyer Cartels: 14. Collusion in the nurse labor market; 15. Collusion in the oocyte market; 16. No-Poaching agreements and antitrust policy; Section V. Mergers and Acquisitions: 17. The economics of horizontal mergers; 18. Horizontal merger policy; 19. The economic theory of vertical integration; 20.

Vertical merger policy; 21. Concluding remarks.ry of vertical integration; 20. Vertical merger policy; 21. Concluding remarks.ry of vertical integration; 20. Vertical merger policy; 21. Concluding remarks.

ry of vertical integration; 20. Vertical merger policy; 21. Concluding remarks.